Samsung recognizes Española Valley High School for innovative Parkinson’s Disease project
Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease. Students, in coordination with ...
Knowridge2d
A new wearable treatment for Parkinson’s motor fluctuations
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Knowridge3d
Research shows major causes of Parkinson’s disease and dementia
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
Hosted on MSN3d
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
Frontiers4d
Therapeutic potential of natural products and their structural analogues in neuropsychiatry
The exploration of natural products and their structural analogues in neuropsychiatry has historically been a fertile area of research, driven by the ...
She was diagnosed with Parkinson’s at 27. These were her warning signs.
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Houston Public Media4d
Spinal stimulation restored muscles wasted by rare genetic disorder
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
Healio4d
GLP-1 does not slow Parkinson’s disease progression in phase 3 study
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Becker's Hospital Review4d
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...